Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04801017
Status:
UNKNOWN
Last Update Posted:
2021-03-16
First Post:
2021-03-01
Brief Title:
A Study to Evaluate the Safety and Efficacy of OT-101Artemisinin in Hospitalized COVID-19 Subjects
Sponsor:
Oncotelic Inc
Organization:
Mateon Therapeutics
Organization Data
Organization:
Mateon Therapeutics
Class:
INDUSTRY
Study ID:
C002 2020 01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncotelic Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None